Bellerophon Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2015 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bellerophon Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2022.
  • Bellerophon Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$1.92M, a 62.1% increase year-over-year.
  • Bellerophon Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$9.25M, a 51.5% increase year-over-year.
  • Bellerophon Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$19.8M, a 11.7% decline from 2021.
  • Bellerophon Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$17.8M, a 28.2% increase from 2020.
  • Bellerophon Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$24.7M, a 86.4% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$19.8M -$2.08M -11.7% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 -$17.8M +$6.97M +28.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$24.7M -$11.5M -86.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-31
2019 -$13.3M -$16.1M -571% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-31
2018 $2.81M +$57.6M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-11
2017 -$54.8M -$31M -130% Jan 1, 2017 Dec 31, 2017 10-K 2020-04-06
2016 -$23.8M +$22.6M +48.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 -$46.5M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.